Abeona Therapeutics Inc. Stock
Abeona Therapeutics Inc. Stock
We can see a decrease in the price for Abeona Therapeutics Inc.. Compared to yesterday it has lost -€0.080 (-1.790%).
With 10 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is potential for a 286.36% increase which would mean more than doubling the current price of 4.4 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | -1.790% | 10.553% | 23.596% | -21.429% | -16.190% | 51.724% | -86.114% |
| Ardelyx Inc. | 0.740% | 2.185% | 3.441% | 0.960% | 1.712% | 197.935% | -3.034% |
| Krystal Biotech | 0.300% | 10.715% | 18.830% | 17.200% | 34.757% | 188.873% | - |
| Evolus Inc | -1.690% | 3.571% | -4.132% | -48.673% | -44.762% | -17.143% | 95.616% |
Comments
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ABEO provided by MarketBeat